162 related articles for article (PubMed ID: 33605413)
1. Bidirectional Ventricular Tachycardia in a Young Female: A Case of Andersen-Tawil Syndrome.
Ransom JL; Wong KC; Kircher J; Usry C; Larson C
Mil Med; 2023 Jan; 188(1-2):e412-e416. PubMed ID: 33605413
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
4. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
5. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
6. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
[TBL] [Abstract][Full Text] [Related]
7. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
8. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic ventricular tachycardia: diagnostic pitfalls of Andersen-Tawil syndrome-a case report.
Nguyen D; Ferns SJ
Eur Heart J Case Rep; 2018 Sep; 2(3):yty083. PubMed ID: 31020160
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
[TBL] [Abstract][Full Text] [Related]
11. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
12. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
14. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
[TBL] [Abstract][Full Text] [Related]
16. Andersen-Tawil Syndrome: A Comprehensive Review.
Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
[TBL] [Abstract][Full Text] [Related]
17. Failure of radiofrequency catheter ablation and success of flecainide to suppress premature ventricular contractions in Andersen-Tawil syndrome: A case report.
Yilmaz S; Kanat S
J Electrocardiol; 2021; 68():37-40. PubMed ID: 34311212
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
[TBL] [Abstract][Full Text] [Related]
19. Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Cruz FM; Bermúdez-Jiménez FJ; Martínez-Carrascoso I; Sánchez-Pérez P; Macías Á; Jalife J
Cardiovasc Res; 2023 May; 119(4):919-932. PubMed ID: 35892314
[TBL] [Abstract][Full Text] [Related]
20. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]